☰

uFraction8

From working prototype to installable product

Industry
Bioprocessing equipment (microfluidic cell separation)
Headquarters
Falkirk, Scotland, United Kingdom
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of uFraction8's published strategy and is not endorsed by, or produced in cooperation with, uFraction8. Company website

Strategic priorities

uFraction8 makes low-shear microfluidic separation hardware for bioprocessing — a modular array of chips, stacks and manifolds that harvests and clarifies live cells without the shear damage of centrifuges or membranes. The company was founded in 2017 by Dr Brian Miller and Dr Monika Tomecka, is headquartered in Falkirk, Scotland, and runs an electronics and R&D subsidiary in Poznań, Poland. Its separation mechanism was published in Nature and independently checked by the National Physical Laboratory on HEK and CHO cell lines with no statistically significant loss of viability across multiple passes.

In February 2025 the company closed a £3.4M seed round led by Foresight Group, with Old College Capital, Scottish Enterprise and a £1.5M PARP grant among the backers, taking total funding to roughly $8.9M. That money is earmarked for one thing: moving from a validated prototype to commercial sales in Europe and North America over the next twelve months, with industrial-size demonstrations and a target of scaling to 20,000L processing capacity.

The Poznań team is building the electronics that turn a passive filter into a connected instrument — the 'Tower', up to five levels of twenty modules each, carrying sensors for real-time process monitoring. That is where the commercial question sits. The customers uFraction8 is selling into — biopharma clarification lines, microalgae harvesting, cultivated-meat producers — buy equipment that drops into an existing digital plant. The step that turns the science into a sellable product is making the Tower's data readable by the systems those plants already run.

Challenges we see

  • Integration Integration

    Speaking the standards a biopharma plant already runs on

    The Poznań team is building the Tower's electronics for real-time monitoring, and the equipment is aimed at regulated biopharma and manufacturing environments. Those plants coordinate their equipment through Module Type Package (MTP) modularity and OPC UA (Open Platform Communications Unified Architecture) communication.

    When a new instrument publishes its data in the same standard form the plant already coordinates, it drops onto the line as a configured module rather than a custom integration project. That is what shifts the buying decision from an engineering evaluation to a purchase.

  • Compliance Regulatory

    Producing audit-ready data alongside the separation

    The bioseparation market uFraction8 sells into is forecast to reach roughly $30B by 2030, and equipment on a GMP line has to produce records that stand up to an FDA or EMA inspection. A published estimate puts an 8 percent yield improvement on a monoclonal antibody at around $72M per year per molecule.

    When the Tower writes its process values as contextualised records with their own trail from the moment they are read, the evidence a customer needs for an audit is produced by the instrument rather than assembled around it. For a vendor, that turns a compliance requirement into a feature the customer can point to.

  • Operations Manufacturing

    Iterating industrial-scale hardware on a seed budget

    The company is moving multiplexed chip stacks from prototype to industrial volumes toward the 20,000L target, on the £3.4M seed round closed in February 2025. Each physical iteration of a precision-geometry stack costs money and time.

    Where control logic and process recipes can be tested against a model before a stack is machined, more of the iteration happens in software, and each physical build carries fewer open questions. For a hardware startup, that stretches the runway the seed round bought.

  • Security Operations

    Shipping a connected instrument that a plant will trust on its network

    As the Tower gains cloud connectivity for remote monitoring, it becomes a device on a pharmaceutical manufacturing network, where buyers apply IEC 62443 and NIS2 expectations before anything is allowed to connect.

    When the device is designed to sit inside a segmented, identity-based network from the start, its security posture is a documented property a buyer can accept, rather than a question raised late in a procurement review.

  • Operations Commercial

    Serving three markets with different requirements from one team

    uFraction8 is entering microalgae harvesting, biopharma clarification and cultivated protein across Europe and North America at the same time, each with its own technical requirements and sales cycle, with a small team and freshly raised capital.

    Where the same instrument can be configured for each market rather than re-engineered, one product platform serves all three. The reusable part is the digital layer — the interfaces, the data model and the recipes — which is where a modest investment covers the most ground.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources

  1. Making the Tower drop onto a line as a configured module

    Regulated plants coordinate equipment through MTP modularity and OPC UA. An instrument that publishes its data in a bespoke form needs custom integration engineering before it can join the line, which is friction the customer feels during the sale.

    MTP-compliant firmware and a standardised operator interface let the Tower present itself as a ready-to-orchestrate module, so a customer adds it to a production line without commissioning integration work — and uFraction8 sells an instrument rather than a project.

    • uFraction8 Poznań 'Tower' concept and IoT integration, uFraction8 news
    • uFraction8 closes £3.4M seed round, Foresight Group, February 2025

  2. Building audit-ready records into the instrument

    Equipment on a GMP line has to produce data that survives an FDA or EMA inspection. Where records are captured by hand or reconstructed later, the burden of proving integrity falls on the customer's quality team.

    Capturing process values at the sensor as contextualised records with their own audit trail, to ALCOA+ and 21 CFR Part 11, means the Tower ships with the evidence its buyers need already attached — a differentiator in a $30B bioseparation market.

    • Bioseparation market forecast, uFraction8 investor materials
    • uFraction8 science page, yield-improvement estimate

  3. Turning sensor data into biological KPIs operators can act on

    The Tower's sensors report raw signals. Without a layer that turns them into separation efficiency, biomass quality and recovery figures, insight arrives after a run rather than during it.

    A monitoring layer that computes the biological KPIs and shows the current run against a reference profile lets operators steer the process live, and gives uFraction8's sales team a visible reason the instrument is worth a premium.

    • uFraction8 real-time process monitoring, Tower concept
    • A4BEE research on bioprocess KPI visualisation

  4. Connecting to the plant's existing instruments and systems

    Biopharma facilities run mixed equipment estates with different protocols and their own LIMS and MES. An instrument that only speaks its own language adds one more island to connect.

    A vendor-neutral connectivity layer over OPC UA and MQTT lets the Tower exchange data with the systems already on site, so it fits a multi-vendor plant without a bespoke bridge per customer.

    • A4BEE research on OPC UA as OT/IT backbone
    • uFraction8 target deployment environments, deep research

  5. Testing separation recipes against a model before machining a stack

    Physical iteration of precision-geometry stacks is slow and capital-intensive, and process conditions for a new application are found today through wet-lab runs.

    A simulation of the separation process, fed by real Tower sensor data, lets engineers explore operating conditions and control logic in software first, so fewer physical builds are needed to reach a working recipe. This is a build-when-ready step, not an immediate blocker.

    • A4BEE research on bioprocess digital twins
    • uFraction8 20,000L scale-up roadmap, deep research

What we'd propose

  • Digital CDMO

    MTP and OPC UA interfaces for the Tower

    We build the Tower's control firmware to the MTP standard and add an OPC UA interface, so the instrument presents itself to a plant as a ready-to-orchestrate module with a standardised operator screen — sized as a product feature, not an enterprise programme.

    • MTP module description

      The Tower described as a standard module

      Package the Tower's services and parameters as an MTP module to the VDI/VDE/NAMUR 2658 standard, so a customer's orchestration layer can drive it without bespoke integration code.

    • OPC UA data interface

      One documented way in and out

      Expose process values and commands over OPC UA so the instrument's data leaves in a documented, vendor-neutral form that a plant's SCADA, LIMS or MES can read directly.

    • Standardised operator screen

      One interface across every unit

      Design a consistent operator interface for the Tower so training and error-prevention carry over from one installation to the next, rather than each customer meeting a different screen.

    • The Tower is bought as an instrument that installs itself onto a line, not a project that needs integration engineering.
    • The same MTP and OPC UA interface serves every customer, so integration is built once rather than per sale.
    • Sales conversations shift from a technical evaluation to a purchase decision.

    We've done this before

    See how we do Digital CDMO
  • Digital Lab

    Audit-ready data capture inside the instrument

    We build validated data capture into the Tower so process values are recorded at the sensor with an audit trail to ALCOA+ and 21 CFR Part 11, giving uFraction8's regulated customers inspection-ready evidence out of the box.

    • Capture at the sensor

      Records made where the data is read

      Record process values as they are read, with instrument identity, timestamp and method context attached, so the data is contextualised from source rather than transcribed later.

    • Audit trail to 21 CFR Part 11

      Records that hold up in an inspection

      Implement electronic-record, signature and versioning handling to 21 CFR Part 11 and ALCOA+, so the evidence chain stands on its own when a customer is inspected.

    • Export in the customer's format

      Data the plant can file

      Provide the captured records in the structures a GMP customer already files against, so the Tower's output slots into their batch record instead of needing rework.

    • The Tower ships with the compliance evidence its buyers need already attached.
    • The customer's quality team inherits records rather than rebuilding them.
    • Audit-readiness becomes a feature the sales team can name in a $30B regulated market.

    We've done this before

    See how we do Digital Lab
  • Enterprise AI

    Live process intelligence for the Tower

    A monitoring layer that turns the Tower's raw sensor signals into biological KPIs — separation efficiency, biomass quality, recovery — and shows the current run against a reference profile, so operators steer the process while it runs.

    • Biological KPI engine

      Signals turned into meaning

      Compute yield, viability preservation and recovery from the raw sensor streams, so operators read biology rather than voltages.

    • Run-against-reference view

      This run next to the best run

      Overlay the current run on a stored reference profile so a deviation is visible while the batch is still on the line, not after it.

    • Topology dashboards

      The instrument as you see it

      Lay the readings out against the Tower's physical layout so an operator finds the relevant number where the hardware actually is.

    • Operators correct a run in progress instead of reviewing it after the fact.
    • The instrument carries a visible reason it is worth a premium.
    • The same monitoring layer works across microalgae, biopharma and protein applications.

    We've done this before

    See how we do Enterprise AI
  • Digital CDMO

    Vendor-neutral connectivity for mixed plants

    A connectivity layer that lets the Tower exchange data with the instruments and systems already on a customer's site over OPC UA and MQTT, so it fits a multi-vendor plant without a bespoke bridge per installation.

    • Multi-protocol connectors

      Speaking the plant's languages

      Read and write across OPC UA, MQTT and common instrument protocols so the Tower joins a heterogeneous estate rather than standing apart from it.

    • Segmented network design

      Connected and contained

      Design the device's network placement with segmentation and identity-based access, so it connects to the plant without widening its attack surface — meeting the IEC 62443 expectations buyers apply.

    • LIMS and MES handoff

      Into the systems of record

      Map the Tower's data onto the customer's LIMS and MES records so results land in the systems the plant already runs on.

    • The Tower fits a mixed-vendor plant without custom integration for each customer.
    • Its network posture is documented, so it clears a security review rather than stalling in one.
    • One connectivity layer covers deployments across all three target markets.

    We've done this before

    See how we do Digital CDMO
  • Agents

    AI agents for grant and regulatory document work

    Narrow, reviewable agents that take the repetitive part of a small team's paperwork: drafting grant progress reports from project records, assembling first drafts of regulatory submission sections, and checking a document against its template before it goes out. A named person approves every output.

    • Grant report drafting

      First drafts from project records

      Draft NCBiR, PARP and Innovate UK progress reports from the underlying project and milestone records, so the team edits and signs rather than assembles from scratch — a real load for a grant-funded startup.

    • Submission section drafting

      First drafts of regulatory text

      Generate first drafts of the recurring sections of an FDA or EMA submission from source data, leaving the technical judgement to the author.

    • Template and completeness check

      Gaps found before it goes out

      Check a document against its template and checklist and flag missing sections before it leaves the building, so a small team catches gaps without a dedicated reviewer.

    • The paperwork that comes with grants and submissions takes less of a small team's time.
    • Documents leave complete, so they clear review faster.
    • Every output traces back to the records it came from and is signed off by a named person.

    We've done this before

    See how we do Agents

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what uFraction8's own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Standardised interfaces 45 → 85
The Tower carries IoT electronics from the Poznań team, and MTP-compliant firmware plus an OPC UA interface would let it present as a standard module. This work is ahead of the product rather than behind it.
Data capture and integrity 40 → 85
Sensor data collection exists on the Tower. Building validated capture with an audit trail to ALCOA+ and 21 CFR Part 11 into the instrument is what a GMP customer needs, and it is the next step toward the biopharma market.
Process analytics 35 → 78
Real-time monitoring is nascent; turning raw signals into biological KPIs and a run-against-reference view would let operators steer a run live and give the product a visible edge.
Device network security 32 → 75
As the Tower gains cloud connectivity it becomes a device on a customer's network, where IEC 62443 and NIS2 expectations apply. Designing segmentation and identity-based access in from the start clears a procurement review.
Simulation and modelling 22 → 68
Process conditions are found today through physical runs. A simulation fed by Tower sensor data would move more iteration into software, which stretches a seed-stage hardware budget. This is a build-when-ready step.
Operator experience 48 → 82
The engineering is strong; a consistent, MTP-aligned operator interface across every unit would cut training and user error and help the instrument sell into high-pressure production environments.

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with uFraction8, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].